Adverse Drug Reaction/Error Champions

Patient safety

Partner Organisations

  • Sandwell and West Birmingham Hospitals NHS Trust

Themes

  • Education and skills

Date Initiated

31 March 2014

Project Status

In Progress

The Adverse Drug Reaction/Error Champions programme has reaped dividends, with the recruitment of error champions at the majority of NHS acute trusts in the region. The first three months of the programme alone has shown an 18% increase in Yellow Card reports across the West Midlands, while those NHS organisations with error champions showed an increase in reports of up to 200%.

Planned outcomes were:

  • To improve the reporting rate of suspected Adverse Drug Reactions (ADRs) across the region
  • To adopt ADR ‘champions’ as advocates to disseminate information on the importance of reporting and to recruit a Lead ADR champion to coordinate and drive the project across the West Midlands.

Programme Outcomes

  • The Lead ADR champion (Karamjit Khangura) was recruited and in turn she has recruited the champions at the majority of NHS acute trusts in the region.
  • The ADR lead pharmacist has met with 17 trusts and three large CCGs within the West Midlands.
  • Approximately 200 healthcare professionals have received face-to-face training/education information from the Yellow Card Centre since October 2014.
  • Early data has shown that the first three months of the project has shown an 18% increase in Yellow Card reports across the West Midlands.
  • The majority of CCGs and acute trusts that have ADR champions have had an increase in reports of up to 200%
  • Delivery of an education day to encourage collaboration between hospital sites and maintain momentum of drug safety reporting. This has enabled champions to get to know each other and share good practice, which in turn helps them to support professionals at their respective site.
  • Delivery of a Celebrating 50 Years of the Yellow Card event on 23 February 2015 at the regional Yellow Card Centre (City Hospital, Sandwell and West Birmingham Hospitals NHS Trust), which was oversubscribed and had a full turnout of 98 attendees from across the West Midlands. The event saw an exciting programme of keynote lectures and case studies presented by patients, healthcare professionals and including national representation from the Medicines and Healthcare products Regulatory Agency (MHRA). Information gathered, results and feedback for the event have been published on the regional website (http://www.yccwm.org.uk/), creating a greater community and background for research and informative purposes.
  • Improved reporting means that there is greater awareness of the causes of adverse drug reactions and more information provides greater potential for patient safety and the avoidance of such episodes and subsequent health interventions.

Programme Lead

Christopher Anton
e: christopher.anton@nhs.net
t: 0121 371 8061